Luca Baldini

14.9k total citations · 1 hit paper
261 papers, 7.8k citations indexed

About

Luca Baldini is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Luca Baldini has authored 261 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Pathology and Forensic Medicine, 107 papers in Oncology and 106 papers in Genetics. Recurrent topics in Luca Baldini's work include Lymphoma Diagnosis and Treatment (118 papers), Chronic Lymphocytic Leukemia Research (89 papers) and Multiple Myeloma Research and Treatments (69 papers). Luca Baldini is often cited by papers focused on Lymphoma Diagnosis and Treatment (118 papers), Chronic Lymphocytic Leukemia Research (89 papers) and Multiple Myeloma Research and Treatments (69 papers). Luca Baldini collaborates with scholars based in Italy, United States and Israel. Luca Baldini's co-authors include Antonino Neri, Lilla Cro, Riccardo Dalla‐Favera, Maiolo At, Ulf Klein, Anna Teresa Maiolo, Sonia Fabris, Luigia Lombardi, Michela Mattioli and Massimo Federico and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Luca Baldini

250 papers receiving 7.6k citations

Hit Papers

Gene Expression Profiling... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells
    2001 704 citations Michela Mattioli, Lilla Cro et al. The Journal of Experimental Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Luca Baldini 3.7k 2.8k 2.5k 2.3k 1.9k 261 7.8k
Marco Ladetto 4.2k 1.1× 1.7k 0.6× 2.9k 1.2× 1.6k 0.7× 1.6k 0.9× 175 7.2k
Paul J. Kurtin 5.1k 1.4× 2.8k 1.0× 3.6k 1.4× 3.3k 1.5× 1.5k 0.8× 235 11.4k
Yasuhiro Oki 3.1k 0.8× 1.7k 0.6× 2.3k 0.9× 2.2k 1.0× 1.3k 0.7× 207 6.3k
Lorenz Trümper 3.9k 1.1× 2.1k 0.7× 3.3k 1.3× 1.9k 0.8× 1.0k 0.5× 203 7.5k
David J. Inwards 4.4k 1.2× 2.1k 0.8× 3.8k 1.5× 1.3k 0.6× 1.9k 1.0× 265 8.0k
Lisa M. Rimsza 3.5k 0.9× 1.6k 0.6× 2.6k 1.0× 1.4k 0.6× 1.2k 0.6× 199 6.2k
Michinori Ogura 3.2k 0.9× 1.8k 0.7× 3.0k 1.2× 1.2k 0.5× 1.5k 0.8× 223 7.3k
Ivana N. Micallef 3.3k 0.9× 1.7k 0.6× 3.2k 1.3× 1.3k 0.6× 2.9k 1.5× 256 7.4k
Francesc Bosch 5.6k 1.5× 4.3k 1.6× 3.4k 1.4× 2.0k 0.9× 1.2k 0.6× 243 8.7k
Sonali M. Smith 4.2k 1.1× 2.3k 0.8× 3.3k 1.3× 1.3k 0.6× 1.3k 0.7× 263 6.8k

Countries citing papers authored by Luca Baldini

Since Specialization
Citations

This map shows the geographic impact of Luca Baldini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Baldini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Baldini more than expected).

Fields of papers citing papers by Luca Baldini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Baldini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Baldini. The network helps show where Luca Baldini may publish in the future.

Co-authorship network of co-authors of Luca Baldini

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Baldini. A scholar is included among the top collaborators of Luca Baldini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Baldini. Luca Baldini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cattaneo, Daniele, Cristina Bucelli, Alfredo Marchetti, et al.. (2023). Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort. Annals of Hematology. 102(6). 1409–1420. 9 indexed citations
2.
Ronchetti, Domenica, Paola Monti, Giovanna Cutrona, et al.. (2020). NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome. Non-Coding RNA. 6(1). 11–11. 10 indexed citations
3.
Marcheselli, Raffaella, Alessia Bari, Tamar Tadmor, et al.. (2020). Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma. Hematological Oncology. 38(4). 439–445. 5 indexed citations
4.
Montefusco, Vittorio, Alessandro Corso, Mónica Galli, et al.. (2020). Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse. British Journal of Haematology. 188(6). 907–917. 7 indexed citations
5.
Iurlo, Alessandra, Francesca Palandri, Elena Maria Elli, et al.. (2020). Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series. Hematological Oncology. 39(1). 123–128. 1 indexed citations
6.
Iurlo, Alessandra, Elena Maria Elli, Francesca Palandri, et al.. (2019). Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach. Hematological Oncology. 37(4). 424–433. 2 indexed citations
7.
8.
Pompa, Alessandra, Francesca Guidotti, Maria Goldaniga, et al.. (2016). Outpatient Stem Cell Mobilization with Intermediate-Dose Cyclophosphamide Is a Safe and Effective Procedure. Blood. 128(22). 5734–5734.
9.
10.
Visco, Carlo, Francesco Maura, Giacomo Tuana, et al.. (2012). Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-cell Receptors. Clinical Cancer Research. 18(7). 1870–1878. 20 indexed citations
11.
Salvo, Giovanni Di, Biagio Castaldi, Luca Baldini, et al.. (2011). Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. Journal of Human Hypertension. 25(12). 739–745. 39 indexed citations
12.
Pacileo, Giuseppe, Luca Baldini, Giuseppe Limongelli, et al.. (2011). Prolonged left ventricular twist in cardiomyopathies: a potential link between systolic and diastolic dysfunction. European Journal of Echocardiography. 12(11). 841–849. 50 indexed citations
13.
Pruneri, Giancarlo, Maurilio Ponzoni, Andrés J.M. Ferreri, et al.. (2006). The prevalence and clinical implications of c‐kit expression in plasma cell myeloma. Histopathology. 48(5). 529–535. 12 indexed citations
14.
Goldaniga, Maria, Andrea Ferrario, Sergio Cortelazzo, et al.. (2005). CD5 negative chronic B cell leukemias : a polycentric retrospective study. Haematologica. 90. 119–119. 1 indexed citations
15.
Federico, Massimo, Umberto Vitolo, Carola Boccomini, et al.. (2001). Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.. PubMed. 86(9). 951–8. 62 indexed citations
16.
Federico, Massimo, Antonio Frassoldati, Teresa Lamparelli, et al.. (1994). Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL. Annals of Oncology. 5(8). 725–731. 16 indexed citations
17.
Baldini, Luca, Andrea Guffanti, D Castagnone, et al.. (1994). Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis. British Journal of Haematology. 86(3). 657–658. 9 indexed citations
18.
Neri, Antonino, James P. Murphy, Lilla Cro, et al.. (1989). Ras oncogene mutation in multiple myeloma.. The Journal of Experimental Medicine. 170(5). 1715–1725. 145 indexed citations
19.
Scheithauer, Werner, et al.. (1987). VAD protocol for treatment of advanced refractory multiple myeloma. Annals of Hematology. 55(3). 145–152. 5 indexed citations
20.
Padova, Franco Di, E. Morandi, D Mazzei, et al.. (1979). Is long-term immunosuppressive treatment necessary to maintain good kidney graft function?. BMJ. 2(6187). 421.2–422. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Ladetto Breakdown of academic impact, for papers by Paul J. Kurtin Breakdown of academic impact, for papers by Yasuhiro Oki Breakdown of academic impact, for papers by Lorenz Trümper Breakdown of academic impact, for papers by David J. Inwards Breakdown of academic impact, for papers by Lisa M. Rimsza Breakdown of academic impact, for papers by Michinori Ogura Breakdown of academic impact, for papers by Ivana N. Micallef Breakdown of academic impact, for papers by Francesc Bosch Breakdown of academic impact, for papers by Sonali M. Smith
Rankless by CCL
2026